Red Light Holland Re-Engages Former Health Minister, the Honourable, Tony P. Clement, as Senior Advisor to Advisory Board

Toronto, Ontario–(Newsfile Corp. – November 14, 2023) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company”), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws, is pleased to announce that it has re-engaged the Honourable, Tony P. Clement, to serve as Senior Advisor to its Advisory Board. Mr. Clement has had a long and distinguished career in politics, law and business. In his role as Senior Advisor, Mr. Clement will continue to work closely with the others members of the Advisory Board, including the Chair, Bruce Linton and the Chief Executive Officer of the Company, Todd Shapiro, to provide strategic advice concerning the Company’s compliance and lobbying efforts for international expansion and hopeful future developments on Canadian expansion as well. Mr. Clement will also help with investor relations to guide the Company’s current and future business development.

“We thoroughly enjoy working with The Honourable Tony Clement and we are so pleased that we have re-engaged with him, as a Senior Advisor to Red Light. Tony, while being a proud card carrying Conservative, believes that being a part of positive change for this world regarding mental health and wellness should always be a bi-partisan progressive initiative. We are proud to have him on our outstanding team,” said Todd Shapiro, the Chief Executive Officer and Director of Red Light Holland.

“I feel strongly that greater access to psilocybin options under proper care and regulations can help Canadians suffering from trauma, PTSD, depression and anxiety. Canadians of all political stripes can support more mental health options, which will alleviate the need for medical assistance in dying in some cases,” added Tony Clement. “Red Light Holland has come along way since I first signed on with them, including expanding quite significantly in the exotic mushroom sector via farming production and on the scientific side with CCrest Labs in my former hometown of Montreal. I’m excited to be a part of their next steps focused on growth and education.”

Mr. Clement served in senior roles in Prime Minister Stephen Harper’s Cabinet (2006-2015), as Health Minister, Industry Minister and President of the Treasury Board. As a business entrepreneur, he has also led information technology companies, and served on the board of directors on information technology and health care companies, having provided strategic advice both nationally and internationally. Having both national and international business experience, Mr. Clement’s engagement magnifies the Company’s commitment to assembling the group of skilled leaders necessary to build its business in the early stage of this emerging industry.

About Red Light Holland

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-643-TRIP (8747)
Email: todd@redlight.co
Website: www.RedLight.co

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events.

The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the Company’s performance, business objectives and milestones and the anticipated timing thereof, and costs in connection with, the execution or achievement of such objectives and milestones, including its plans to work with Tony Clement and the stated goals of this Advisory Position; and the future growth of mushroom sales across North America and Europe.

Forward-Looking information in this press release are based on certain assumptions and expected future events, namely: the Company’s ability to carryout its plans to work with Tony Clement and achieve the stated goals of this executive role; the execution or achievement of such objectives and milestones; the Company and the Company’s partners’ abilities, the Company’s ability to continue developing its products that can potentially be accessible in emerging legal markets worldwide; and the Company’s ability to provide updates with respect to its continued work with its mushroom partners and produce and homegrown kits.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the Company’s inability to carry out its plans to work with Tony Clement and achieve the stated goals of this executive agreement; the Company’s inability to maintain or exceed its current performance, and carry out its business objectives and milestones and under the anticipated timing and costs in connection with, the execution or achievement of such objectives and milestones; the Company’s inability to continue developing its products for mushroom products, truffle products and microdosing that can potentially be accessible in emerging legal markets worldwide; and the Company’s inability to provide updates with respect to its continued work with its partners on the microdosing capsules. There are no guarantees that Government’s across the world will allow easier access to the Company’s psilocybin homogenized capsules.

Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-Looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/187311